Persistent interferon-β-1b-induced psychosis in a patient with multiple sclerosis

Psychiatry and Clinical Neurosciences

Volumn 64, Issue 5, 2010, Pages 584-586

  Manfredi, Giovanni ^a,b   Kotzalidis, Giorgio D ^a   Sani, Gabriele ^a,b   Koukopoulos, Alexia E ^a,b   Savoja, Valeria ^a   Lazanio, Simone ^a   Girardi, Nicoletta ^a   Tatarelli, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Centro Lucio Bini   (Italy)

Author keywords

delusions; hallucinations; interferon 1b; multiple sclerosis; psychosis

Indexed keywords

HALOPERIDOL; INTERFERON BETA SERINE; LORAZEPAM; MITOXANTRONE; OLANZAPINE; BETA INTERFERON; NEUROLEPTIC AGENT;

ADD ON THERAPY; ADULT; AGGRESSIVENESS; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; DELUSION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HOSPITAL DISCHARGE; HUMAN; INSOMNIA; INTROSPECTION; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; PSYCHOSIS; RELAPSE; RESTLESSNESS; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; AGGRESSION; BRAIN; CHEMICALLY INDUCED DISORDER; FORENSIC PSYCHIATRY; HALLUCINATION; PARANOID PSYCHOSIS; PATHOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

ADULT; AGGRESSION; ANTIPSYCHOTIC AGENTS; BRAIN; COMMITMENT OF MENTALLY ILL; DELUSIONS; HALLUCINATIONS; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PARANOID DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 77957333559     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2010.02122.x     Document Type: Article

References (16)

1. Kornischka J, Burtscheidt W, Gaebel W. Interferoninduzierte paranoide Psychose. Literaturübersicht und Kasuistik. Nervenarzt 2002 73 : 463 467. (Pubitemid 36062354)
2. Feinstein A. The neuropsychiatry of multiple sclerosis. Can. J. Psychiatry. 2004 49 : 157 163. (Pubitemid 38506493)
3. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J. Neurol. Neurosurg. Psychiatry 2005 76 : 469 475.
4. Patten SB, Beck CA, Williams JV, Barbui C, Metz LM. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003 61 : 1524 1527. (Pubitemid 37505573)
5. Goeb J-L, Cailleau A, Lainé P, Gohier B, Dubas F, Garré JB. Psychiatric side effects of interferon-beta in multiple sclerosis. Eur. Psychiatry 2006 21 : 186 193.
6. Goëb JL, Cailleau A, Lainé P et al. Acute delirium, delusion, and depression during IFN - 1a therapy for multiple sclerosis: a case report. Clin. Neuropharmacol. 2003 26 : 5 7. (Pubitemid 36184108)
7. Reiss JP, Sam D, Sareen J. Psychosis in multiple sclerosis associated with left temporal lobe lesions on serial MRI scans. J. Clin. Neurosci. 2006 13 : 282 284. (Pubitemid 43294494)
8. Monji A, Yoshida I, Tashiro K, Hayashi Y, Tashiro N. A case of persistent manic depressive illness induced by interferon-alfa in the treatment of chronic hepatitis C. Psychosomatics 1998 39 : 562 564. (Pubitemid 28515886)
9. Schäfer M, Boetsch T, Laakmann G. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C. Addiction 2000 95 : 1101 1104. (Pubitemid 30480269)
10. Tamam L, Yerdelen D, Ozpoyraz N. Psychosis associated with interferon alfa therapy for chronic hepatitis B. Ann. Pharmacother. 2003 37 : 384 387. (Pubitemid 36249639)
11. Telio D, Sockalingam S, Stergiopoulos V. Persistent psychosis after treatment with interferon alpha: a case report. J. Clin. Psychopharmacol. 2006 26 : 446 447. (Pubitemid 44187660)
12. Thome J, Knopf U. Acute psychosis after injection of pegylated interferon alpha-2a. Eur. Psychiatry 2003 18 : 142 143. (Pubitemid 36644320)
13. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 1981 30 : 239 245. (Pubitemid 12149145)
14. Asghar-Ali AA, Taber KH, Hurley RA, Hayman LA. Pure neuropsychiatric presentation of multiple sclerosis. Am. J. Psychiatry 2004 161 : 226 231. (Pubitemid 38419272)
15. Moore JO, Olsen GA. Mitoxantrone in the treatment of relapsed and refractory acute leukemia. Semin. Oncol. 1984 11 (3 Suppl. 1 41 46. (Pubitemid 15221432)
16. Dresler M, Genzel L, Kluge M et al. Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression. Psychoneuroendocrinology 2010. doi:10.1016/j.psyneuen.2010.02.005.